Medical Affairs - Apprentice at Eli Lilly and Company

Mexico City, Mexico City, Mexico

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

Part TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Currently pursuing a bachelor's degree in Health Sciences (e.g., Medicine, Biomedicine, Biotechnology, Genomic Sciences) or related fields with applications in health (e.g., Data Science, Biomedical Engineering, Biology, QFB, QFI), with estimated graduation in July 2026 or later
Advanced level of English and proficiency in digital tools
Genuine interest in applying knowledge to understand and contribute to improving diseases affecting the population
Organizational, analytical, and conceptual thinking skills; ability to handle information in a structured and methodical way
Strong communication skills, interpersonal relations, motivation, and willingness for continuous learning
Proactivity, analytical thinking, clear and timely communication, and results-oriented mindset

Responsibilities

Collaborate with a high-level scientific and medical team, providing support in managing relationships with key opinion leaders in various therapeutic areas to meet requirements for executing medical education programs
Actively contribute to the construction, integration, monitoring, and proper safeguarding of medical information related to main therapeutic areas
Provide key support in medical area governance processes, ensuring compliance with legal, regulatory, and internal Lilly policies to generate better outcomes for more patients
Support administrative management of purchase orders, payments to healthcare professionals and academic societies, ensuring traceability and compliance with established processes
Use internal platforms such as Supplier 360 (Ariba, AP, WwTP, C3, CM LATAM), TLMAP, Veeva Events, and others to track operational processes in the area
Contribute knowledge, propose new ideas, and implement projects that optimize daily activities of the medical team and cross-functional teams
Understand key needs of the health ecosystem, collaborating in the development of innovative digital tools that strengthen interaction with main stakeholders and generate sustainable results for patients

Skills

Medical Affairs

Key Opinion Leader Management

Medical Education

Regulatory Compliance

Purchase Orders

Payments Processing

Supplier 360

Ariba

TLMAP

Veeva Events

Healthcare Ecosystem

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free